VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.6100
-0.0025 (-0.41%)
At close: Apr 10, 2026, 4:00 PM EDT
0.6051
-0.0049 (-0.80%)
After-hours: Apr 10, 2026, 7:49 PM EDT
VYNE Therapeutics Market Cap
VYNE Therapeutics has a market cap or net worth of $20.33 million as of April 10, 2026. Its market cap has decreased by -21.85% in one year.
Market Cap
20.33M
Enterprise Value
-8.68M
1-Year Change
-21.85%
Ranking
Category
Stock Price
$0.61
Market Cap Chart
Since March 10, 2020, VYNE Therapeutics's market cap has decreased from $229.74M to $20.33M, a decrease of -91.15%. That is a compound annual growth rate of -32.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 20.33M | 5.27% |
| Dec 31, 2025 | 19.31M | -60.93% |
| Dec 31, 2024 | 49.42M | 51.96% |
| Dec 29, 2023 | 32.52M | 273.57% |
| Dec 30, 2022 | 8.71M | -84.05% |
| Dec 31, 2021 | 54.59M | -79.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Barinthus Biotherapeutics | 23.18M |
| Lexaria Bioscience | 22.65M |
| Jasper Therapeutics | 22.46M |
| Vistagen Therapeutics | 22.20M |
| Lantern Pharma | 22.08M |
| AEON Biopharma | 21.25M |
| NanoViricides | 21.22M |
| Quantum BioPharma | 21.04M |